Sienna Biopharmaceuticals(OTC) SNNA

Market CapN/A

Since IPO (2017)-100%

5 Year-99%

1 Year+9,900%

1 Month+9,900%

N/A

Sienna Biopharmaceuticals last closing stock price
Metric	Price	Date
Last close	USD 0.00	2026-08-20

Sienna Biopharmaceuticals stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+9,900%	USD 0.00	2026-06-23
1 month	+9,900%	USD 0.00	2026-06-23
3 month	+9,900%	USD 0.00	2026-04-22
Year to date	+9,900%	USD 0.00	2025-12-17
1 year	+9,900%	USD 0.00	2025-08-15
3 year	+0%	USD 0.00	2023-08-17
5 year	-98.75%	USD 0.01	2021-08-20
Since inception	-100%	USD 19.25	2017-07-27

Sienna Biopharmaceuticals Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$0.00

Net Income (TTM)

-$121.99M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

N/A

SNNA News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sienna Biopharmaceuticals

Sienna Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that focuses on the discovery, clinical development, and commercialization of aesthetics and medical dermatology. Its products include Topical by Design platform for patients with inflammatory skin diseases and other dermatologic and aesthetic conditions through SNA-120, SNA-125, and SNA-001. The company was founded by Todd Harris and Frederick C. Beddingfield III on July 27, 2010 and is headquartered in Westlake Village, CA.

Industry

Pharmaceuticals

Sector

Health Care

SNNA Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-124.76%

Return on Capital

-108.96%

Return on Assets

-68.47%

Earnings Yield

N/A

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$121.61M

EBITDA

-$125.24M

Operating Cash Flow

-$54.63M

Capital Expenditure

-$10.00K

Free Cash Flow

-$54.64M

Cash & ST Invst.

$11.33M

Total Debt

$941.00K

Sienna Biopharmaceuticals Performance Analysis

Sienna Biopharmaceuticals sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2018-12-31	N/A
Q1	2019-03-31	N/A
Q2	2019-06-30	N/A
Q3	2019-09-30	N/A

Sienna Biopharmaceuticals sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2018-12-31	-35.0%
Q1	2019-03-31	84.1%
Q2	2019-06-30	-50.9%
Q3	2019-09-30	69.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q3 2019YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

-$7.49M

+86.2%

EBITDA

-$12.03M

+77.6%

Quarterly Fundamentals

Name

Q3 2019YOY CHG

Total Cash

$11.33M

-82.3%

Total Debt

$941.00K

-96.9%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$941.00K

-96.9%

Short Term Debt

$0.00

N/A

Return on Assets

-68.47%

N/A

Return on Invested Capital

-92.21%

N/A

Free Cash Flow

-$17.84M

-12.2%

Operating Cash Flow

-$17.84M

-12.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,684.24-0.00%

^DJIDJI

^DJIDJI$53,254.61-0.01%

^IXICNASDAQ

^IXICNASDAQ$26,319.55-0.00%

BTCBitcoin

BTCBitcoin$78,890.00-0.00%

SPCXSPCX

SPCXSPCX$142.81+0.01%

AAPLAAPL

AAPLAAPL$315.25-0.01%

AMZNAMZN

AMZNAMZN$258.45-0.03%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

WETOWetour Robotics

WETOWetour Robotics$5.48-0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$71.92+0.00%

INTCIntel

INTCIntel$89.51+0.00%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$44.67+0.02%

NVDANvidia

NVDANvidia$220.78+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.97+0.11%

SOFISoFi Technologies

SOFISoFi Technologies$17.88-0.01%

Questions About SNNA

What is the current price of Sienna Biopharmaceuticals?

Sienna Biopharmaceuticals is trading at N/A per share.

What is the 52-week range for Sienna Biopharmaceuticals?

Over the past 52 weeks, Sienna Biopharmaceuticals has traded between N/A and N/A.

How much debt does Sienna Biopharmaceuticals have?

Sienna Biopharmaceuticals total debt is unavailable.

How much cash does Sienna Biopharmaceuticals have on hand?

Sienna Biopharmaceuticals does not have cash on hand data available.

What is Sienna Biopharmaceuticals’s dividend yield?

Sienna Biopharmaceuticals does not currently have a dividend yield.

Sienna Biopharmaceuticals(OTC) SNNA

Sienna Biopharmaceuticals Financials at a Glance

SNNA News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Sienna Biopharmaceuticals

SNNA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Sienna Biopharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SNNA

What is the current price of Sienna Biopharmaceuticals?

What is the 52-week range for Sienna Biopharmaceuticals?

How much debt does Sienna Biopharmaceuticals have?

How much cash does Sienna Biopharmaceuticals have on hand?

What is Sienna Biopharmaceuticals’s dividend yield?

Premium Investing Services